News for 'SARS CoV'

Fighting COVID-19: Why you should clean your nose

Fighting COVID-19: Why you should clean your nose

Rediff.com11 May 2020

Satish Kumar Bhat, 47 from Delhi shared some suggestions that he feels may help fight coronavirus.

IIT study finds Covid traces in Sabarmati river, 2 lakes

IIT study finds Covid traces in Sabarmati river, 2 lakes

Rediff.com18 Jun 2021

A recent study by researchers at the Indian Institute of Technology (IIT) Gandhinagar has established the presence of coronavirus in water samples from the Sabarmati river and two lakes in Ahmedabad city of Gujarat.

Health secy reviews status of passengers from UK

Health secy reviews status of passengers from UK

Rediff.com23 Dec 2020

Union Health Secretary Rajesh Bhushan reviewed the status of passengers coming from the UK to India and found positive in Maharashtra, Karnataka, Telangana, Tamil Nadu, West Bengal, Goa, Punjab, Gujarat and Kerala and their response measures in a meeting held through video conferencing.

Saudi Arabia suspends international travel over new Covid strain

Saudi Arabia suspends international travel over new Covid strain

Rediff.com21 Dec 2020

All people who have arrived in Saudi Arabia from European countries, as well as other states where the new coronavirus strain has emerged, will have to self-isolate at home for two weeks. Those who have visited these countries in the past three months will need to get tested for Covid-19, according to SPA.

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Rediff.com25 Jun 2023

He also said that it was wrong to suggest that India stopped foreign made vaccines like that made by Moderna and Pfizer from coming to India.

Pak PM tests negative for COVID-19; cases cross 10,000 mark

Pak PM tests negative for COVID-19; cases cross 10,000 mark

Rediff.com22 Apr 2020

Khan, 67, agreed for the test after Faisal Edhi, the son of late philanthropist Abdul Sattar Edhi and chairman of the Edhi Foundation, who met him last week tested positive for the coronavirus.

Indian scientists develop low-cost COVID-19 test, Feluda

Indian scientists develop low-cost COVID-19 test, Feluda

Rediff.com22 Apr 2020

Named after 'Feluda', the detective character in legendary filmmaker Satyajit Ray's stories, the test has been developed by Debojyoti Chakraborty and Souvik Maiti as a simpler way of detecting SARS-coV2 presence in clinical samples, IGIB Director Anurag Agarwal said.

New smartphone-based COVID test gives results in less than 30 minutes

New smartphone-based COVID test gives results in less than 30 minutes

Rediff.com7 Dec 2020

The research found that the device accurately detected a set of positive samples in under 5 minutes.

Pfizer withheld Covid vaccine news before elections: Trump

Pfizer withheld Covid vaccine news before elections: Trump

Rediff.com10 Nov 2020

Trump had said that he worked on removing a large number of bureaucratic obstacles to fast-track development and approval of a vaccine.

'Omicron won't be a big challenge for India'

'Omicron won't be a big challenge for India'

Rediff.com6 Dec 2021

... 'Or any country which has reasonable vaccine coverage.' 'The emergence of Omicron clearly proves that if we allow a virus to circulate in an unvaccinated population, it would take a form which could be a Variant of Concern, or a new variant.'

PM holds high-level meet amid rise in Covid cases

PM holds high-level meet amid rise in Covid cases

Rediff.com22 Mar 2023

India has recorded 1,134 new coronavirus cases, while the active cases increased to 7,026, according to the Union health ministry data updated on Wednesday.

Gallbladder gangrene reported in post-Covid patients

Gallbladder gangrene reported in post-Covid patients

Rediff.com16 Sep 2021

Doctors claimed it is the first time that cases of gallbladder gangrene have been reported after recovery from COVID-19 infection.

Nortje out of quarantine after false COVID-19 scare

Nortje out of quarantine after false COVID-19 scare

Rediff.com16 Apr 2021

The Proteas speedster, a star performer for DC in the last edition, had tested positive for COVID-19 while in quarantine. But was retested and came out negative in three RT-PCR results.

Trump to 'work from hospital' for next few days, says 'doing well'

Trump to 'work from hospital' for next few days, says 'doing well'

Rediff.com3 Oct 2020

"Out of an abundance of caution, and at the recommendation of his physician and medical experts, the president will be working from the presidential offices at Walter Reed for the next few days," White House Press Secretary Kayleigh McEnany said on Friday, a day after he was tested positive for COVID-19.

Air pollution may hinder India's fight against COVID-19: Scientists

Air pollution may hinder India's fight against COVID-19: Scientists

Rediff.com27 Oct 2020

Long-term exposure to chronically high PM2.5 levels weakens the ability of the lungs to fend off infections, therefore making people more susceptible to COVID-19, the scientists said.

Fear of second Covid wave as people moving out: Maha CM

Fear of second Covid wave as people moving out: Maha CM

Rediff.com26 Sep 2020

Thackeray directed officials to ensure that people follow health norms like wearing masks, and that violators be fined.

Taj Mahal opens with all COVID-19 norms in place

Taj Mahal opens with all COVID-19 norms in place

Rediff.com21 Sep 2020

To keep up with the COVID guidelines, the site has imprinted norms saying not more than 5,000 visitors are allowed in a day. Also, group photographs are not at all encouraged. Guards are keeping strict vigil so that tourists do not touch the railing and walls of the monument and used tissue paper, mask, gloves shoe covers are dumped in the dustbin.

Labs bet on Covid tests for next growth phase

Labs bet on Covid tests for next growth phase

Rediff.com14 Sep 2020

The bouquet of Covid-19 tests that most diagnostic labs are offering include antibody tests (blood tests), rapid antigen tests (point of care tests that detect the presence of an antigen from a nasal or throat swab in case of SARS-CoV-2), and reverse transcription-polymerase chain reaction (RT-PCR) tests.

Rapid antigen tests are spuriously comforting: Scientists

Rapid antigen tests are spuriously comforting: Scientists

Rediff.com11 Sep 2020

'There are not enough RT-PCR tests and they take a long time to do in specialised centres. So the world is using RA tests for the same reason that India is using them, and with similar somewhat spuriously comforting rationale'

INSACOG suggests booster doses for people above 40 years

INSACOG suggests booster doses for people above 40 years

Rediff.com3 Dec 2021

'Vaccination of all remaining unvaccinated at-risk people and consideration of a booster dose for those 40 years of age and over, first targeting the most high-risk / high-exposure may be considered,' the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG) said in its weekly bulletin dated November 29.

A, B blood groups, Rh+ people more prone to Covid: Study

A, B blood groups, Rh+ people more prone to Covid: Study

Rediff.com30 Nov 2021

People having blood group of A, B and those with Rh factor positive are "more susceptible to COVID-19 infection" compared to those having O or AB group and Rh negative, according to a new study conducted by doctors at a Delhi hospital.

COVID cases increasingly reported from rural areas: Experts

COVID cases increasingly reported from rural areas: Experts

Rediff.com31 Aug 2020

The experts said there is a need to relook at the testing strategy in a way that it results in guiding the public health response and effectively limiting the spread of the disease.

Oxford launches COVID-19 vaccine study on children

Oxford launches COVID-19 vaccine study on children

Rediff.com13 Feb 2021

This new trial, a single-blind, randomised Phase II trial, will enrol 300 volunteers, with up to 240 of these volunteers receiving the ChAdOx1 nCoV-19 vaccine and the remainder a control meningitis vaccine, which has been shown to be safe in children but is expected to produce similar reactions, such as a sore arm.

Johnson & Johnson says its Covid shot neutralises Delta variant

Johnson & Johnson says its Covid shot neutralises Delta variant

Rediff.com2 Jul 2021

In the ensemble trial, Johnson & Johnson's vaccine was 85 per cent effective against severe/critical disease and demonstrated protection against hospitalisation and death. The vaccine was consistently effective across all regions studied globally, including in South Africa and Brazil, where there was a high prevalence of rapidly emerging Beta and Zeta variants during the study period.

First Covid case may have emerged in China in Oct 2019: Study

First Covid case may have emerged in China in Oct 2019: Study

Rediff.com25 Jun 2021

The research, published in the journal PLOS Pathogens on Thursday, suggests that the first case of COVID-19 arose between early October and mid-November, 2019 in China, with the most likely date of origin being November 17.

Omicron subvariant BA.2 spreads faster, may cause severe disease: Study

Omicron subvariant BA.2 spreads faster, may cause severe disease: Study

Rediff.com18 Feb 2022

The yet-to-be peer-reviewed findings, recently posted on the preprint repository BioRxiv, show that the BA.2 sub variant may have features that make it as capable of causing serious illness as older coronavirus variants.

Men more likely to suffer severe effects of COVID-19 than women: Study

Men more likely to suffer severe effects of COVID-19 than women: Study

Rediff.com29 Apr 2020

Based on the observations, scientists said that additional care may be required for older men or those with underlying conditions. Yang and his team analysed several patient datasets to see if there were differences in how men and women respond to COVID-19.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

'None of the existing vaccines can prevent emerging variants of Omicron'

'None of the existing vaccines can prevent emerging variants of Omicron'

Rediff.com25 Jan 2023

'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'

India-UK flights to remain suspended till Jan 7: Puri

India-UK flights to remain suspended till Jan 7: Puri

Rediff.com30 Dec 2020

The civil aviation ministry had last week suspended all flights between the European country and India from December 23 to December 31 as a mutated variant of the coronavirus was detected there.

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Rediff.com9 Jun 2021

Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of Covaxin.

COVID-19 adds new words to the dictionary!

COVID-19 adds new words to the dictionary!

Rediff.com24 May 2020

'Great social change brings great linguistic change, and that has never been truer than in this current global crisis.'

Covid deaths could touch 1 million by August: Lancet

Covid deaths could touch 1 million by August: Lancet

Rediff.com8 May 2021

If that outcome were to happen, the Modi government would be responsible for presiding over a self-inflicted national catastrophe.

Six feet gap not enough to prevent virus spread, says study

Six feet gap not enough to prevent virus spread, says study

Rediff.com15 Sep 2021

Physical distancing of two metres - about six and a half feet - may not be enough to sufficiently prevent transmission of virus-carrying airborne aerosols indoors, says a study.

WHO again asks China to regularly share real-time data on Covid situation

WHO again asks China to regularly share real-time data on Covid situation

Rediff.com31 Dec 2022

The global health agency has asked Chinese health officials to share data on genetic sequencing, hospitalisations, deaths and vaccinations.

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Rediff.com28 Apr 2021

The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.

Mask Up, Covid Is Not Over Yet

Mask Up, Covid Is Not Over Yet

Rediff.com22 Dec 2022

'If there are any symptoms/variants of concern, states can prepare accordingly.'

Omicron study: Sputnik V and Light booster effective

Omicron study: Sputnik V and Light booster effective

Rediff.com22 Dec 2021

Russia's Sputnik V vaccine and its one-shot version Sputnik Light booster demonstrates high virus-neutralising activity (VNA) against the highly-contagious Omicron variant of COVID-19, providing a strong defence against severe disease and hospitalisation, according to a study.